DAG Investments
Long only, value, growth, long-term horizon

Anacor Pharmaceuticals: A Rally Forthcoming?

Article Scope

As mentioned in my Seeking Alpha profile, I'm a long-term investor, but I also sometimes trade short-term opportunities. The fact that I'm discussing Anacor Pharmaceuticals (NASDAQ:ANAC) from the short-term opportunity perspective does not mean that I consider the stock unsuitable for long-term investment. In fact, I only cover stocks that have potential to evolve into long-term investments.

The scope of this article is limited since I am not a pharmacologist or physician and do not have deep insight into the medical viability of developmental-stage pharmaceuticals. Thus, the article scope is to offer updates on ANAC from my first article on the company. It is not to speculate on the medical viability or potential FDA approval...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details